[ad_1]
With the rise in interest of various psychedelic drugs for a range of conditions (MDMA for PTSD, and ketamine and psilocybin mushrooms for treatment-resistant depression, to name a few), it seems only fair that we should pay serious attention to other substances in this family that might treat other conditions.
Introducing ibogaine. Well, not quite introducing. The fairly-obscure African plant, used traditionally in Gabon, was first patented in the United States for use ...
[ad_1]
… seeks out “underground healers” in an attempt to address her depression, anxiety, PTSD and opioid addiction with magic mushrooms and iboga.
[ad_2]
Source link
[ad_1]
Heroin is a commonly abused opioid nowadays. Horse, cheese, smack, gum- by any name, it is a killer drug!
Since an addict will try every possible thing to hide his/her addictive behavior, it is quite tough to detect the situation. However, you can quickly address the drug’s high by capturing the visible signs or track marks.
[ad_1]
SAN DIEGO (KGTV) – People across the country are crossing the border to Mexico, hoping an alternative form of therapy will cure their addiction to opioids.
One former addict shared his story with 10News. He asked that we only refer to him as Bob.
“I had been to traditional rehabs throughout my life, mostly against my will,” said Bob.
He said he got hooked on painkillers after multiple injuries due to skateboarding and snowboarding.
His addiction ...
[ad_1]
Gary A. Enos, Editor
A Toronto-based company is looking to have an impact on the treatment of opioid addiction by exploring the potential of psychedelics, an area of study that to this point has seen more intense activity in the mental health field.
Mind Medicine Inc. (Mindmed) announced this week that it has acquired the drug development program for 18-MC (18-methoxycoronaridine), a synthetic derivative of the psychedelic drug ibogaine. The company is preparing ...